The potD gene, belonging to the well-conserved ABC (ATP-binding cassette) transport system potABCD, encodes the bacterial substrate-binding subunit of the polyamine transport system. In this study, we found PotD in Haemophilus (Glaesserella) parasuis could actively stimulate both humoral immune and cellular immune responses and elevate lymphocyte proliferation, thus eliciting a Th1-type immune response in a murine immunity and infection model. Stimulation of Raw 264.7 macrophages with PotD validated that Toll-like receptor 4, rather than 2, participated in the positive transcription and expression of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α using qPCR and ELISA. Blocking signal-regulated JNK-MAPK and RelA(p65) pathways significantly decreased PotD-induced pro-inflammatory cytokine production. Overall, we conclude that vaccination of PotD could induce both humoral and cellular immune responses and provide immunoprotection against H. parasuis challenge. The data also suggest that Glaesserella PotD is a novel pro-inflammatory mediator and induces TLR4-dependent pro-inflammatory activity in Raw 264.7 macrophages through JNK-MAPK and RelA(p65) pathways.
Introduction
Haemophilus (Glaesserella) parasuis is a pleomorphic, nonmotile, nicotinamide adenine dinucleotide (NAD)-dependent bacterium belonging to the family Pasteurellaceae and causes Glasser's disease (GD) in piglets [1] . H. parasuis is primarily readily isolated in weaner pigs, followed by finisher pigs and sows [2] . It normally colonizes the upper respiratory tract of swine and includes strains with diverse genetics and pathogenicities [3] . When a host is under stress, virulent strains can penetrate the mucosal barrier and enter the bloodstream, causing severe vascular lesions and multiple syndromes [4] . Clinical Table 1 . Primers used in this study.
Primers
Primer Sequences ( Lowercase letters are homologous recombination fragments required for in-fusion clone to the vectors. Restriction enzyme sites BamHI (ggatcc) and HindIII (aagctt) are shown in bold characters.
Expression/Purification of Recombinant PotD Protein, and Removal of Endotoxin Contamination
Expression of recombinant protein of PotD (rPotD) was performed using an E. coli expression system. Briefly, PCR fragments containing H. parasuis potD gene minus a 22 amino acid signal peptide sequence were amplified from genomic DNA of SC1401 using primers P1 + P2 (potD-pET-F/R, Table 1 ). The resulting 1015 bp PCR products were cloned into the restriction enzyme sites BamHI and HindIII of linearized pET-28a (+) (TaKaRa) using ClonExpress II One Step Cloning Kit (Vazyme, Jiangsu, China), giving rise to pET-potD. When reaching an optical density at 600 nm (OD 600nm ) of 0.5 to 0.6, E. coli BL21(DE3) bearing pET-potD was induced to express by the addition of 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) for 5 h. The culture was spun at 5000g for 10 min, resuspended in 50 mM Tris-HCl, and then lysed by sonication. The lysate was further centrifuged at 12,000g for 10 min to pellet cell debris. The His-tag fusion recombinant protein was purified by Ni affinity chromatography using a Bio-Scale TM Mini Nuvia TM IMAC Ni-Charged Resin (5 mL prepacked column, Bio-Rad, CA, USA). Purified rPotD was dialyzed with 2 L of PBS for 2 days and then analyzed by SDS-PAGE electrophoresis. After being concentrated by a 10 kDa ultrafiltration device (Millipore, Bedford, MA, USA), concentration of recombinant protein was determined using a Modified BCA Protein Assay Kit (Sangon Biotech, Shanghai, China). A ToxinEraser TM Endotoxin Removal Resin (Genscript, Pescataway, NY, USA) was used to treat the purified protein for bringing down endotoxin contamination to lower than 0.1 EU/mL [42] . Chromogenic endpoint LAL assay was adopted to quantify the endotoxin as previously described [43] .
Immunization
Mouse immunization was carried out to determine immune responses and protection against challenging from a heterogeneous H. parasuis SH0165. We performed both active and passive immunization analyses.
For active immunization, thirty SPF BALB/c 6-8-week-old mice were allocated randomly into rPotD, adjuvant, and rPotD+adjuvant groups (T3-T5, 10 mice per group), and another 20 mice were allocated to mock (T1) and PBS (T2) control groups. Each mouse in T5 was routinely immunized with 0.1 mg of rPotD plus one-tenth volume of adjuvant (total volume of 0.2 mL) subcutaneously on the backside. Mice in T3 was vaccinated with only rPotD without adjuvant. In parallel, hosts in groups T2 or T4 were injected with equivalent volume of PBS or adjuvant solely, respectively, as negative controls. The mouse in the mock groups T1 received no treatment, serving as a blank control. All mice were vaccinated and maintained on the same program in the same breeding environment with unlimited food and water. Blood samples were collected two days before the challenge for passive immunization analysis usage. The surviving mice were humanely euthanized 7 days post-infection (dpi).
Analysis of Cellular Immune Response of Mice Using Immunofluorescent (IF) Assay and Flow Cytometry
After mice had been immunized with rPotD protein three times, three animals each from the mock group (immunized with PBS/adjuvant) and immunized group (immunized with rPotD+adjuvant) were humanely euthanized, with their spleens being treated with FFPE (formalin/paraformaldehyde-fixed, paraffin-embedded) and used for IF staining to determine the Vaccines 2019, 7, 216 5 of 28 elevation of immunocyte CD3 + /CD4 + /CD8 + (CD positive T-cells). Photos were shot using a fluorescence microscope (Nikon Eclipse ci&NIKON DS-U3) to detect cyanine (CY3)-labeled fluorescent secondary antibodies (CY3, EX WL: 510-560 nm, EM WL: 590 nm) and analyzed by an immunofluorescence assay using the CaseViewer software. While the fluorescence signal intensities were shown as integrated optical density (IOD) values, analyzed by ImageProPlus software. Relative values of IOD R were calculated by the ratio of the IOD of CY3-fluorescence intensity (IOD C ) and DAPI (IOD D ).
The blood of the three groups was applied to flow cytometry (FCM) analysis to measure lymphocyte subtype. Briefly, 100 µL portions of heparin anticoagulant peripheral blood cells were incubated with 10 µL hamster anti-mouse CD3-FITC, CD4-Percp, and CD8-PE (BD Biosciences, San Diego, CA, USA) for 30 min at RT in the dark. Thereafter, RBC lysing solution (Invitrogen, Carlsbad, CA, USA) was added and incubated for another 5 min. Subsequently, the cocktail was centrifuged at 300g for 5 min, and the supernatant was discarded. Cells were resuspended in 0.5 mL PBS (pH = 7.2-7.4) and detected by a flow cytometer (FACSVerse, BD Biosciences, San Jose, CA, USA) within 1 h. All experiments were performed in triplicate with at least 10,000 cell counts per treatment. The frequencies of T-helper cells (CD3 + CD4 + ) and cytotoxic T-cells (CD3 + CD8 + ) were analyzed by Flowjo software (Flowjo LLC, Ashland, OR, USA). The experiments were independently performed at least three times in triplicate.
Analysis of Lymphocyte Proliferation and Detection of Cytokines Using ELISA
Lymphocyte proliferation assays were performed as previously described with some modifications [44] . Two weeks after booster immunizations of rPotD plus MONTANIDE™ GEL 01 adjuvant, primary spleen lymphocytes from mice in both the mock and immunized groups were separated and maintained for 72 h at 37 • C with 5% CO 2 . Briefly, mice were humanely euthanized and their spleens were isolated aseptically and processed by gentle mechanical disruption using a 10 mL disposable syringe and a sterile cell strainer (40 µm in aperture, Gibco, Grand Island, NY, USA). Splenocytes were flushed down by 5 mL incomplete RPMI-1640 medium (Gibco, USA) suspended in Hank's balanced salt mixture (HBSS, Solarbio, Beijing, China). Red Blood Cell Lysis Buffer (ACK lysis buffer, Coolaber, Beijng, China) was added to remove erythrocytes, and cell suspensions were centrifuged for 5 min at 300g. The erythrocyte-free cells were washed three times with HBSS and then resuspended in complete RPMI-1640 medium. The number of cells was counted and adjusted to 10 7 /mL, and 200 µL of cells were added to 96-well culture plates (Costar, Corning Inc., Corning, NY, USA). The cells were stimulated with the rPotD proteins (10 µg/well), the same volume of concanavalin A (ConA, final mass of 50 µg/well, Sigma-Aldric, St. Louis, MO, USA) or RPMI-1640 medium (mock group), and incubated. Lymphocyte proliferation assays were performed using the MTS reagent with a cell proliferation kit (CellTiter 96 ® AQueous One Solution Reagent, Promega Inc., Madison, WI, USA) according to the manufacturer's specifications. The lymphocytes were incubated in 96-well culture plates with MTS reagent for 4 h, and the absorbance was measured at 490 nm (A 490nm ) using a Varioskan Flash (Thermo Scientific, Waltham, MA, USA).
To determine the type of immune response, we tested the expression of cytokines. The supernatants from cell cultures were harvested after 72 h and stored at −80 • C. The levels of IL-1β, IL-4, and IFN-γ were determined in culture supernatants using the double-antibody sandwich ELISA kits (Beijing 4A Biotech Co., Ltd., Beijing, China), as per manufacturer's specifications.
Mouse Challenge
A week after the booster immunizations (on the 28th day), all mice were challenged intraperitoneally with a lethal dose of highly virulent wild-type H. parasuis strain SH0165 (1.4 × 10 9 CFU, 0.5 mL), except for the mice in the mock group. All mice were monitored continuously daily after the challenge for the presence and severity of respiratory symptoms and general illness or mortality. Clinical symptoms were scored according to murine activity scores, which were recorded by the sum of the following grading standards: poor spirit (1 point), loss of appetite (1 point), hunched posture (1 point), increased heart rate (1 point), fur loss (1 point), and weight loss (1 points). Mice showing more severe symptoms received higher scores [45] . After mice has been challenged for 72 h, three animals in each group were humanely euthanized, their hearts, livers, spleens and lungs being necropsied and treated with FFPE and used for histological examination (H&E) analysis to determine the pathological lesion before or after immunization. To explore the protectivity elicited by mouse IgG antibodies fraction against PotD, a further passive immunization and challenge was analyzed. Briefly, another five groups of 6-8-week-old mice (10 mice per group, T1'-T5', corresponding to T1-T5) were intraperitoneally injected with 100 µL of pooled serum collected from the immunized mice 2 h before the challenge with a lethal dose of wild-type H. parasuis SH0165. All mice were monitored continuously daily and their clinical symptoms were determined routinely as above. The surviving mice were humanely euthanized 7 dpi. The experiments were independently performed two times.
Bacterial Clearance
In order to quantify bacterial clearance after immunization, thirty SPF BALB/c 6-8-week-old mice were allocated randomly into rPotD, adjuvant, and rPotD+adjuvant groups (6 mice per group), and another 12 mice were equally and randomly allocated to mock and PBS control groups. The same grouping scheme also apply to the passive immunization groups. These mice were immunized with rPotD, adjuvant, rPotD+adjuvant, nothing, or PBS (active immunization group), or pre-injected with their corresponding serum collected from the immunized mice as above (passive immunization group). All mice were challenged intraperitoneally with a half lethal dose (HLD) of H. parasuis strain SH0165 (2.4 × 10 8 CFU, 0.5 mL), except for the mice in the mock group. Twelve hours after the booster immunization, serial dilutions were prepared for equivalent volume of lung homogenates from PBS/PotD alone/adjuvant and PotD+adjuvant-inoculated mice in active and passive immunization groups (10 1 -10 7 dilutions in sterile PBS; four lung tissue samples in each immunization group). One hundred microliters per diluted sample were plated on TSA++ supplemented with 200 µL nalidixic acid (100 mg/mL). Plates were incubated at 37 • C overnight, and visible bacterial colonies were counted manually. The number of visible bacteria in the mock group was used as a background reference value. Colonies were identified by PCR. The surviving mice were humanely euthanized immediately after this experiment, so as not to cause them pain.
Cell Line and Culture Conditions
In the next studies, we adopted a mouse monocyte/macrophage leukemia cell line RAW 264.7 to dissect immune indices and signal pathways. RAW 264.7 was cultured in complete modified RMPI-1640 medium (Gibco, USA) containing 10% fetal bovine serum (Gibco, USA), and maintained at 37 • C a humidified incubator with 5% CO 2 . Macrophages (1 mL) were added to 12-well cell culture plates at 1 × 10 6 cells per well. For simulation of PotD protein challenge in vitro, RAW 264.7 cells were stimulated by rPotD protein at a final concentration of 15 or 30 µg/mL for concentration-dependent tests. For detection of immune responsive cell receptors and signal pathways, the cells were collected at 12 h after stimulation. To reduce the possible contamination by bacterial lipopolysaccharide (LPS), polymyxin B (PMB) was added at a final concentration of 10 µg/mL throughout the experiments, except where LPS was utilized as a positive control.
Detected of Pro-Inflammatory Cytokines Induced by PotD Using ELISA and Quantitative Real-Time PCR
For ELISA detection, rPotD was added to Raw 264.7 macrophage culture medium at a final concentration of 15 or 30 µg/mL. LPS (Solarbio, without polymyxin B) was added to a group of three wells in parallel at a concentration of 200 ng/mL to serve as a positive control. An equivalent volume of PBS was added to the negative control group. The cultures were incubated for 12 h, then spun down. The supernatants from cell cultures were harvested after 72 h and stored at −80 • C. The levels of IL-1β, IL-6, and TNF-α were determined in culture supernatants using the double-antibody sandwich ELISA kits (Beijing 4A Biotech Co., Ltd., China), as per the manufacturer's specifications. The experiments were independently performed at least three times in triplicate. For quantitative real-time PCR (qRT-PCR), all treated cultures above were set to incubate for 12 h. Total RNA in each group was extracted using a TRIzol Kit (TaKaRa, Shiga, Japan). Their concentrations were examined by measuring the absorbance at 260 nm (A 260nm ) using a spectrophotometry Smartspec TM Plus (Bio-Rad). The purity of RNA was determined by the ratio of absorbance at 260 and 280 nm. Integrity of RNA was verified using agarose gel electrophoresis (AGE). RT-PCR was performed using an iScript cDNA Synthesis Kit (Bio-Rad). qRT-PCR was performed by using an iTaq TM universal SYBR Green Supermix (Bio-Rad) in a Lightcycler96 (Roche, Basel, Switzerland) system. The relative quantification of 2(−∆∆C(T)) method was used to test transcriptional levels of cytokines IL-1β, IL-6, and TNF-α. Primers for qPCR are listed in Table 1 . GAPDH was used as internal reference gene. The experiments were independently performed at least three times in triplicate.
Toll-Like Receptors 2 (TLR2) and 4 (TLR4) Blocking Assay
To determine macrophage recognition receptors of PotD, we blocked the corresponding Toll-like receptors 2 (TLR2) and 4 (TLR4), and both TLR2/4 on Raw 264.7 macrophage using their corresponding monoclonal antibodies (mAb) (Ultra-LEAF TM Purified anti-mouse/human CD282 (TLR2) and LEAF TM Purified anti-mouse TLR4 (CD284)/MD2 Complex, BioLegend, San Diego, CA, USA). Both antibodies were added to a final concentration of 10 µg/mL. rPotD protein was added to cultured macrophages to a final concentration of 15 µg/mL for 12 h after 30 min pre-treatment with two blocking antibodies. Raw 264.7 were spun down and supernatant was collected for routine detection of cytokines IL-1β, IL-6, and TNF-α using double-antibody sandwich ELISA kits (Beijing 4A Biotech Co., Ltd.). Results were analyzed to determine cytokine response levels and to confirm identity of receptors contributing to the response to rPotD exposure.
Western Blotting Assay for Induction of Pro-Inflammatory Cytokines by PotD
Raw 264.7 macrophage was treated with 15 µg/mL of purified rPotD for 12 h, then spun down. The total protein of rPotD-treated and untreated macrophages was extracted. Briefly, the pelleted suspension cells were resuspended in ice-cold PBS (pH = 7.2−7.4) for 15 min, supplemented with Halt Protease Inhibitor Cocktail and Halt TM Phosphatase Inhibitor Cocktail (Thermo Scientific) to prevent proteolysis and maintain phosphorylation status of proteins. Afterwards, the collected cells were resuspended in phosphate buffered saline (Roche) and RIPA lysis buffer and allowed to sit in an ice bath for 15 min. The concentrations of the total protein were determined using a Modified BCA Protein Assay Kit (Sangon Biotech). Aliquots corresponding to 50 µg of each sample were analyzed using Western blotting (WB) analysis, which was carried out routinely as stated above (potD Mutant Identification). LPS group and PBS group were set as positive and negative control, respectively. The primary antibodies included p-Erk1/2, Erk1/2, p-p38-MAPK, p38-MAPK, p-JNK, JNK, p-p65(NF-κB), p65(NF-κB), TLR2, and TLR4. All antibodies were obtained from Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA. The grayscale bands were developed by the ChemiDoc TM XRS+ system with Image Lab TM software (Bio-Rad). Band luminosity intensity was quantified using ImageJ software. IOD values were analyzed by AlphaEaseFC software, wherein GAPDH was used as internal reference gene.
Determination of Working Concentrations of Inhibitors Using MTT Assay
Prior to inhibiting cell-signaling pathways using inhibitor agents SB203580 (p38-MAPK inhibitor), U0126 (Erk1/2 inhibitor), SP600125 (JNK inhibitor) and PDTC (NF-κB inhibitor), the cytotoxicities of these signaling pathway inhibitors was evaluated in vitro using MTT colorimetric assay. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was obtained from AMRESCO Inc. (Radnor, PA, USA). The macrophages were seeded in triplicate in 96-well plates at a density of 5000 cells/well and incubated at 37 • C, 5% CO 2 overnight to allow the cells to attach to the plate. The medium was removed, and cells were re-incubated with complete DMEM/F-12 medium (Hyclone, Logan, UT, USA) for 24 h at 37 • C, supplemented with different concentrations of inhibitor agents (0, 1, 3, 5, 10, 20 µM each inhibitor per well). Afterwards, treated medium was removed and aliquots of 20 µL of MTT in 5 mg/mL concentration were added to each experimental well. The cocktail was incubated for another 4 h to allow MTT to be reduced to formazan. MTT was removed carefully and the intracellular purple formazan crystals were solubilized by DMSO. Plates were shaken for 10 min before reading them on a spectrophotometer (SmartspecTM Plus, Bio-Rad). The absorbance wavelength was recorded at 570 nm. Cytotoxicity was determined as inhibition ratio, which equals to
, in which A represents the A 570nm of experimental groups (inhibitor agent-treated); A blank represents background wavelength in blank wells (no cell and no agent); A c represents A 570nm in control groups, where cells were treated with MTT but no other inhibiting agent.
Effect of Inhibitor on the MAPK and NF-κB Signal Pathways
Raw 264.7 macrophages (1 × 10 6 cells/mL) were cultured in 12-well cell culture plates. Cells were pretreated with the following specific inhibitors (10 µM each) in parallel for 30 min prior to PotD addition: SB203580 (p38 inhibitor), U0126 (Erk1/2 inhibitor), SP600125 (JNK inhibitor), PDTC (NF-κB inhibitor). Another DMSO (AMRESCO Inc., USA) group was set as a control (final concentration of 1 µL/mL). Inhibitors for studying signal pathways were obtained from MCE (10 mM each, Monmouth Junction, NJ, USA), dissolved in DMSO. Raw 264.7 were spun down and supernatant was collected for routine detection of cytokines IL-1β, IL-6, and TNF-α using ELISA kits. Results were analyzed to determine cytokine response levels and to confirm identity of cell-signaling pathways contributing to responses to rPotD exposure.
Statistical Analysis
Comparisons of several independent test series were evaluated by analysis of two-way analysis of variance (ANOVA tests). Multiple comparisons between any two means of different groups were performed using least significant difference (LSD) method. Values were presented as mean values plus or minus the standard deviation from the mean (SD). A p value was generated for all variables, with p < 0.05 considered to be statistically significant (*).
Results

Purification of rPotD Protein, Endotoxin Elimination, and Polyclonal Antibody Preparation
rPotD protein was expressed as a fusion protein in its active form with both of its C-terminal and N-terminal 6 × His tags, facilitating the purification process using a Ni affinity chromatography in vitro. The products were dialyzed, ultra-filtrated and analyzed using 12% SDS-PAGE, while the E. coli BL21 strain harboring the empty pET-28a (+) vector alone served as a negative control. One band with the molecular mass of approximately 39 kDa, corresponding to rPotD protein plus its recombinant tag, was obtained as expected ( Figure 1 ), indicating that the rPotD protein was successfully expressed in BL21(DE3) under the induction by 1 mM of IPTG for 5 h at 30 • C. After endotoxin removal, the concentration of endotoxin was less than 0.1 EU per mL in the purified rPotD. The purified rPotD was subsequently used to vaccinate mice and treat macrophages.
A week after booster immunization, blood samples from each mouse were collected by retro-orbital bleeding. After the serum was precipitated, a 96-well plate coated with purified rPotD protein was used to detect the specific antibody titers of mouse antiserum against rPotD via ELISA. Results showed that immunization with 0.1 mg of rPotD could sufficiently elicit a specific antibody titer up to nearly 1 × 10 6 ( Figure 2 ). The antiserum was adopted to determine the construction of potD gene mutant and complemented strains in later studies. The titer was defined as the absorbance of the highest dilution at 450 nm which was at least 0.1 above that of the background wells in which serum samples were replaced with PBS. Short vertical lines indicate value below detection limit. These experiments were repeated four times. Each error bar represents one standard deviation from the mean.
Recombinant PotD Protein Mediates a Cellular Immune Response
In addition to the finding that rPotD can actively elicit the humoral immune response, we further performed IF and FCM analyses to determine whether rPotD could trigger the upregulation of certain T cells in mice. The spleens of three mice in each group were treated with FFPE and used for routine IF analysis. The fluorescence staining showed that all CD molecules were located on the surface of spleen lymphocytes, forming circular fluorescence bodies ( Figure 3B ). IOD R assay of normal spleen tissues revealed low-threshold immunofluorescence in white pulp area ( Figure 3A ). However, no conspicuously visible CD molecule could be observed in red pulp area. Closer inspection of the relative expression levels of immunocyte CD3 + /CD4 + /CD8 + revealed that all CD3 + /CD4 + /CD8 + were upregulated to almost twice that of the mock group upon inoculating rPotD+adjuvant in mice (p < 0.05). Clumping of T cells CD3 + and CD4 + clustered in white pulp area, while CD8 + was scattered in red pulp area, despite a low fluorescence intensity. However, mice immunized with pure adjuvant solely or injected with PBS only showed insignificant fluctuations in cell line levels, when compared with the mock group (p > 0.05) ( Figure 3B ). 
In addition to the finding that rPotD can actively elicit the humoral immune response, we further performed IF and FCM analyses to determine whether rPotD could trigger the upregulation of certain T cells in mice. The spleens of three mice in each group were treated with FFPE and used for routine IF analysis. The fluorescence staining showed that all CD molecules were located on the surface of spleen lymphocytes, forming circular fluorescence bodies ( Figure 3B ). IODR assay of normal spleen tissues revealed low-threshold immunofluorescence in white pulp area ( Figure 3A ). However, no conspicuously visible CD molecule could be observed in red pulp area. Closer inspection of the relative expression levels of immunocyte CD3 + /CD4 + /CD8 + revealed that all CD3 + /CD4 + /CD8 + were upregulated to almost twice that of the mock group upon inoculating rPotD+adjuvant in mice (p < 0.05). Clumping of T cells CD3 + and CD4 + clustered in white pulp area, while CD8 + was scattered in red pulp area, despite a low fluorescence intensity. However, mice immunized with pure adjuvant solely or injected with PBS only showed insignificant fluctuations in cell line levels, when compared with the mock group (p > 0.05) ( Figure 3B ). In FCM assay, total T cells (mature T lymphocytes) and the T cell subsets T-helper cells (CD4 + ) and T suppressors/cytotoxic T-cells (CD8 + ) were quantitated in a representative peripheral blood sample of untreated or immunized mice (fluorescence-activated cell sorting, FACS, Supplementary Materials, Figure S1 ). The distribution of CD8 + leukocyte infiltrates was somewhat different from the findings in IF assay. In two independent experiments, CD8 + respectively accounted for 14.18% and 14.61% of the whole cells ( Figure S1 ), which were even slightly lower than those in the mock group, presumably because the different sensitivities in different detection methods and/or different samples (spleen tissue vs. peripheral blood), but the differences were not significant (p > 0.05). However, immunized mice-blood samples displayed magnification of CD3 and CD4 T lymphocytes (CD3 + , CD4 + ) frequencies (p < 0.05). Relative CD3 + counts rose from 24.3% to a robust 33.76%/40.4% cells; CD4 + increased from 16.61% to 23.86%/29.08% cells (p < 0.05). On the other hand, CD4 + /CD8 + increased from 0.931 (16.61/17.84) to 1.648 (23.86/14.48)/1.990 (29.08/14.61); this was presumably attributable to the immunization of rPotD. Significantly, both the CD3 + and CD4 + count and CD4 + /CD8 + ratios were upregulated almost one and a half times that observed in the mock group, which was in accordance with the findings in the IF assay, where their relative fluorescence intensities (IODR) nearly doubled in mice inoculated with rPotD+adjuvant.
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Overall, these observations corroborated the suggestion that rPotD can actively mediate a cellular immune response through stimulating the expressions of CD3 + , CD4 + and elevating CD4 + /CD8 + in mice.
Lymphocyte Proliferation Assay and Detection of Cytokines
The lymphocyte proliferation assay set out with the aim of assessing the importance of possessing the level of rPotD immunogenicity and immune-protective efficacy. Splenocytes of mice two weeks after booster immunization were isolated and stimulated with rPotD protein and ConA. Levels of lymphocyte proliferation in each group were detected using an MTS method and the results shown as absorbance at A 490nm . As shown in Figure 4 , a significantly ascending proliferative lymphocyte immune response was observed in the mice immunized with rPotD+adjuvant (p < 0.05). Similarly, a strong lymphocyte cell proliferative response was detected when stimulated with ConA as a positive control (p < 0.05). However, compared with mock group, neither rPotD-alone group nor adjuvant-alone group elicited a significant proliferative splenocyte response when using rPotD, rather than ConA, as a stimulant. The proliferative splenocytes response may prove useful in blunting pathogenicity levels induced by H. parasuis infection. 
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rPotD-Vaccinated Mice Show Less Severe Pathological Signs in Multiple Tissues
Given that rPotD can actively elevate lymphocyte proliferation and induce Th1-type immune response related to pro-inflammatory cytokines, we first evaluated the immunoprotective effect of rPotD in the mice model, prior to validating its immune protective effect in piglets. The rPotD+adjuvant group showed a mortality rate of 30% (3/10) upon challenge with H. parasuis SH0165, while the PBS/rPotD-alone/adjuvant-alone groups displayed rates of 100% mortality within 48 h ( Figure 6A ). Through monitoring, we found mice that survived in the rPotD+adjuvant presented less severe clinical symptoms than the mice in the PBS/rPotD-alone/adjuvant-alone groups. Most infected hosts in the latter group scored 5-7 within 24-48 h post-infection using the murine activity scores system, while most mice in rPotD+adjuvant group scored 1-4 or less within 48-72 h post-challenge; nearly all of them recovered fully, minus the dead hosts. No anomalies were observed in the mock group throughout the experiment. In passive immunization, all the mice receiving antisera elicited by PBS/rPotD alone/adjuvant alone died after the challenge with H. parasuis SH0165 within 36 h. One half of mice (5/10) immunized passively with antisera from rPotDmixed with adjuvant were protected from the lethal H. parasuis challenge ( Figure 6B) , and nearly all of the survivors recovered fully within 72 h. In the active immunization experiment, after the mice were humanely sacrificed, hearts, livers, spleens and lungs were harvested and treated with FFPE, and further utilized for H&E analysis to determine pathological lesion severity levels. As shown in Figure 7 (lungs) and Supplementary Materials, Figure S2 (hearts, livers, spleens), pathological lesions were present in all immunized groups. However, compared with PBS/rPotD-alone/adjuvant-alone groups, mice in rPotD+adjuvant group showed less severe pathological lesions. In the rPotD+adjuvant group, lung sections exhibited alveolar wall thickening accompanied by certain pulmonary lymphocytic infiltration; this group also displayed local alveolar dilation, thinned alveolar walls, and extrusion of surrounding alveoli, and a small amount of alveoli wall rupturing (Figure 7) ; spleen sections showed small areas of myocardial fiber necrosis, nuclear pyknosis, deep staining or dissolution, accompanied 
Given that rPotD can actively elevate lymphocyte proliferation and induce Th1-type immune response related to pro-inflammatory cytokines, we first evaluated the immunoprotective effect of rPotD in the mice model, prior to validating its immune protective effect in piglets. The rPotD+adjuvant group showed a mortality rate of 30% (3/10) upon challenge with H. parasuis SH0165, while the PBS/rPotD-alone/adjuvant-alone groups displayed rates of 100% mortality within 48 h ( Figure 6A ). Through monitoring, we found mice that survived in the rPotD+adjuvant presented less severe clinical symptoms than the mice in the PBS/rPotD-alone/adjuvant-alone groups. Most infected hosts in the latter group scored 5-7 within 24-48 h post-infection using the murine activity scores system, while most mice in rPotD+adjuvant group scored 1-4 or less within 48-72 h post-challenge; nearly all of them recovered fully, minus the dead hosts. No anomalies were observed in the mock group throughout the experiment. In passive immunization, all the mice receiving antisera elicited by PBS/rPotD alone/adjuvant alone died after the challenge with H. parasuis SH0165 within 36 h. One half of mice (5/10) immunized passively with antisera from rPotDmixed with adjuvant were protected from the lethal H. parasuis challenge ( Figure 6B) , and nearly all of the survivors recovered fully within 72 h. In the active immunization experiment, after the mice were humanely sacrificed, hearts, livers, spleens and lungs were harvested and treated with FFPE, and further utilized for H&E analysis to determine pathological lesion severity levels. As shown in Figure 7 (lungs) and Supplementary Materials, Figure S2 (hearts, livers, spleens), pathological lesions were present in all immunized groups. However, compared with PBS/rPotD-alone/adjuvant-alone groups, mice in rPotD+adjuvant group showed less severe pathological lesions. In the rPotD+adjuvant group, lung sections exhibited alveolar wall thickening accompanied by certain pulmonary lymphocytic infiltration; this group also displayed local alveolar dilation, thinned alveolar walls, and extrusion of surrounding alveoli, and a small amount of alveoli wall rupturing (Figure 7) ; spleen sections showed small areas of myocardial fiber necrosis, nuclear pyknosis, deep staining or dissolution, accompanied by a certain amount of lymphocytic infiltration in several pathology bearing regions ( Figure S2C ). Other areas displayed no such pathological changes. By contrast, in the adjuvant-alone group, lung sections showed severe alveolar wall epithelial cell necrosis, nuclear pyknosis, and deep staining or fragmentation accompanied by a mass of lymphocytic infiltration; capillary congestion, large amounts of red blood cells in the lumen of the blood vessels, and hemorrhaging were also observed ( Figure 7) ; spleen sections exhibited deeper level of myocardial fiber necrosis, nuclear dissolution, cytoplasmic loose staining, and significant myocardial fiber edema surrounding the tissue (Figure S2C ). Heart and liver sections displayed similar pathological signs ( Figure S2A,B) . No anomalies were observed in the mock group. by a certain amount of lymphocytic infiltration in several pathology bearing regions ( Figure S2C ). Other areas displayed no such pathological changes. By contrast, in the adjuvant-alone group, lung sections showed severe alveolar wall epithelial cell necrosis, nuclear pyknosis, and deep staining or fragmentation accompanied by a mass of lymphocytic infiltration; capillary congestion, large amounts of red blood cells in the lumen of the blood vessels, and hemorrhaging were also observed ( Figure 7) ; spleen sections exhibited deeper level of myocardial fiber necrosis, nuclear dissolution, cytoplasmic loose staining, and significant myocardial fiber edema surrounding the tissue ( Figure  S2C ). Heart and liver sections displayed similar pathological signs ( Figure S2A,B) . No anomalies were observed in the mock group.
(A) (B) 
rPotD+Adjuvant-Vaccinated Mice Showed Significantly Elevated Bacterial Clearance Ability
To assess the specific pathogen scavenging ability of PotD in the innate immune response in vivo, we subjected SPF BALB/c mice to a HLD of H. parasuis strain SH0165. Lung tissue homogenates were diluted serially and cultured on nalidixic acid-containing TSA++ overnight prior to counting the visible bacterial colonies (in a series of dil. 10 1 -10 7 ). In the mock group, the number of visible bacteria ranged from 125-327 CFU/mL in active immunization, and 69-204 CFU/mL in passive immunization, severing as a background reference value. As expected, a statistically significant decrease in viable bacteria was detected in lung tissue homogenate from rPotD+adjuvant-immunized mice compared to those from all the other non-effective immune groups (Figure 8 ). Thus, we concluded that Hp-rPotD could trigger effective clearance of H. parasuis during acute pneumonia to prevent systemic infections. This may underscore the way in which rPotD+adjuvant-immunization could protect mice from certain dose of H. parasuis infection under lab conditions and may possess the potential to endow the host with the resistance against H. parasuis colonization in lungs in murine models.
rPotD Actively Elevates the Levels of Pro-Inflammatory Cytokines IL-1β, IL-6, and TNF-α
We have demonstrated using a mouse model that rPotD can effectively induce Th1-type immune responses in spleen cells. To analyze the function of PotD antigen in pathogenesis, pro-inflammatory cytokine responses were measured on Raw 264.7 macrophages. After macrophages were treated with rPotD protein, secreted cytokines IL-1β, and IL-6, and TNF-α in the supernatant of cell culture were determined using ELISA kits. After treatment with rPotD, the secretion level of all three cytokines in the supernatant of cell culture was significantly upregulated compared with the negative control (p < 0.05). Additionally, 30 µg/mL of rPotD triggered a statistically significant increase in all three cytokines than 15 µg/mL of rPotD, showing a strong correlation between higher rPotD concentration and increased cytokine induction levels. LPS (200 ng/mL) served as a positive control, which promoted the upregulation of the production of all these cytokines, while low secretion levels of IL-1β, and IL-6, TNF-α were obtained in the negative control (treated with PBS) (Figure 9 ). 
rPotD+Adjuvant-Vaccinated Mice Showed Significantly Elevated Bacterial Clearance Ability
To assess the specific pathogen scavenging ability of PotD in the innate immune response in vivo, we subjected SPF BALB/c mice to a HLD of H. parasuis strain SH0165. Lung tissue homogenates were diluted serially and cultured on nalidixic acid-containing TSA++ overnight prior to counting the visible bacterial colonies (in a series of dil. 10 1 -10 7 ). In the mock group, the number of visible bacteria ranged from 125-327 CFU/mL in active immunization, and 69-204 CFU/mL in passive immunization, severing as a background reference value. As expected, a statistically significant decrease in viable bacteria was detected in lung tissue homogenate from rPotD+adjuvant-immunized mice compared to those from all the other non-effective immune groups (Figure 8 ). Thus, we In transcriptional levels, the relative quantification of 2(−∆∆C(T))-based qRT-PCR method was performed to test transcriptional levels of all three cytokines. GAPDH was utilized as internal reference gene. The mRNA levels of IL-1β, IL-6, and TNF-α were significantly increased (Supplementary Materials, Figure S3 , p < 0.05) compared with negative controls, indicating activation and pro-inflammatory activity of macrophages. Likewise, 30 µg/mL of rPotD displayed statistically significant increased transcriptional levels in all three cytokines than 15 µg/mL of rPotD, which was in correlation with ELISA results, showing that rPotD can actively promote the Th1-type pro-inflammatory cytokines activation of macrophages at both protein and mRNA levels. Plates were incubated at 37 °C overnight, and visible bacterial colonies were counted manually. Graph represents mean ± SD for 4 mice/group for each treatment (* indicates a significant difference (p < 0.05) between groups of immune treatment using paired t-test, and plus sign indicates mean value in each group.).
rPotD Actively Elevates the Levels of Pro-Inflammatory Cytokines IL-1β, IL-6, and TNF-α
We have demonstrated using a mouse model that rPotD can effectively induce Th1-type immune responses in spleen cells. To analyze the function of PotD antigen in pathogenesis, proinflammatory cytokine responses were measured on Raw 264.7 macrophages. After macrophages were treated with rPotD protein, secreted cytokines IL-1β, and IL-6, and TNF-α in the supernatant of cell culture were determined using ELISA kits. After treatment with rPotD, the secretion level of all three cytokines in the supernatant of cell culture was significantly upregulated compared with the negative control (p < 0.05). Additionally, 30 µg/mL of rPotD triggered a statistically significant increase in all three cytokines than 15 µg/mL of rPotD, showing a strong correlation between higher rPotD concentration and increased cytokine induction levels. LPS (200 ng/mL) served as a positive control, which promoted the upregulation of the production of all these cytokines, while low secretion levels of IL-1β, and IL-6, TNF-α were obtained in the negative control (treated with PBS) (Figure 9 ).
In transcriptional levels, the relative quantification of 2(−ΔΔC(T))-based qRT-PCR method was performed to test transcriptional levels of all three cytokines. GAPDH was utilized as internal reference gene. The mRNA levels of IL-1β, IL-6, and TNF-α were significantly increased (Supplementary Materials, Figure S3 , p < 0.05) compared with negative controls, indicating activation and pro-inflammatory activity of macrophages. Likewise, 30 µg/mL of rPotD displayed statistically significant increased transcriptional levels in all three cytokines than 15 µg/mL of rPotD, which was 
TLR4, Rather Than TLR2, Participates in Regulatory Role on Expression of Pro-Inflammatory Cytokines in Macrophages
Toll-like receptors (TLR) 2 and 4 were separately or collectively blocked using anti-TLR2 and anti-TLR4 monoclonal antibodies in an effort to prove that rPotD upregulated cytokine production through binding with macrophage cell surface recognition receptors. ELISA results demonstrated that production of the three pro-inflammatory cytokines increased significantly after TLR4 was blocked compared with the rPotD group (Figure 10) , especially IL-6 and TNF-α, which declined from 95.68 ± 2.34 and 112.73 ± 1.74 pg/mL to 46.36 ± 0.28 and 67.68 ± 7.68 pg/mL, respectively. The declines were nearly two-fold. However, in the anti-TLR2 or anti-TLR2/4 group, secreted levels of all of the three pro-inflammatory cytokines had no significant changes (p > 0.05). Taken together, these results indicated that TLR4, rather than TLR2, mediated PotD-induced expression of pro-inflammatory cytokines in macrophages in H. parasuis infection. 
Toll-like receptors (TLR) 2 and 4 were separately or collectively blocked using anti-TLR2 and anti-TLR4 monoclonal antibodies in an effort to prove that rPotD upregulated cytokine production through binding with macrophage cell surface recognition receptors. ELISA results demonstrated that production of the three pro-inflammatory cytokines increased significantly after TLR4 was blocked compared with the rPotD group (Figure 10) , especially IL-6 and TNF-α, which declined from 95.68 ± 2.34 and 112.73 ± 1.74 pg/mL to 46.36 ± 0.28 and 67.68 ± 7.68 pg/mL, respectively. The declines were nearly two-fold. However, in the anti-TLR2 or anti-TLR2/4 group, secreted levels of all of the three pro-inflammatory cytokines had no significant changes (p > 0.05). Taken together, these results indicated that TLR4, rather than TLR2, mediated PotD-induced expression of pro-inflammatory cytokines in macrophages in H. parasuis infection. . Figure 11 . MTT Analysis of cytotoxicities of signaling pathway inhibitors (inhibitory rate curve). Cytotoxicities of signaling pathway inhibitors SB203580 (p38-MAPK inhibitor), U0126 (Erk1/2 inhibitor), SP600125 (JNK inhibitor), and PDTC (NF-κB inhibitor) were determined as an inhibition ratio, which is equal to (1 − (A − Ablank)/(Ac − Ablank)), in which A represents the A570nm of experimental groups (inhibitor agent-treated); Ablank represents background wavelength in blank wells (no cell and no agent); Ac represents A570nm in control groups, where cells were only treated with MTT agent, but not any inhibitor agent. These experiments were repeated 3 times. Each error bar represents one standard deviation from the mean. 
Determination of Working Concentrations of Inhibitors Using MTT Assay
An MTT assay was carried out to determine the cytotoxicities of signaling pathway inhibitors SB203580 (p38-MAPK inhibitor), U0126 (Erk1/2 inhibitor), SP600125 (JNK inhibitor), and PDTC (NF-κB inhibitor), prior to being applied to block their corresponding signaling pathways. According to manufacturing instructions, the recommended concentration for SB203580/U0126/SP600125/PDTC was 1-50 µM/1-20 µM/1-100 µM/10-100 µM, respectively. However, in this study, we found 10 µM of each signaling pathway inhibitor induced a slight inhibiting effect on cell line Raw 264.7, while 20 µM of each inhibitor, especially the SB203580 and SP600125, demonstrated significant higher levels of inhibitory effects on cell growth (inhibitory rate > 10%) ( Figure 11 ). The Raw 264.7-inhibitory rates for SB203580/U0126/SP600125/PDTC were 26.65%/12.60%/22.97%/14.37%, respectively. Thus, in later studies, we used 10 µM each as the optimized working concentration, which was efficacious enough that this concentration was much higher than their corresponding IC 50 for signaling pathway inhibition according to the product specifications, and 10 µM of these inhibitors had negligible cytotoxic effects to cell line Raw 264.7.
Production of Pro-Inflammatory Cytokines Mainly through JNK-MAPK and NF-κB Signal Pathways
For further investigation of the signal pathways for PotD engaged in boosting pro-inflammatory cytokines, Western blotting was carried out to determine three MAPK pathways, including p38, ERK, JNK signal molecules, and another RelA(p65) signal molecule belonging to the NF-κB pathway. As outlined in Figure 12 , only the phosphorylation of JNK-MAPK in Raw 264.7 cells induced by PotD stimulation was augmented significantly, while the expression levels of the other signal molecules fluctuated within a statistically insignificant range (p > 0.05). The raw data of western blotting used in this study in Supplementary Materials, Figure S4 . Figure 10 . Analysis of the recognition receptor of PotD. Anti-TLR2 and anti-TLR4 monoclonal antibodies were used to block their corresponding Toll-like receptor or both TLR-2/4. Protein levels of (A) IL-1β, (B) IL-6, and (C) TNF-α in the culture supernatants were determined by ELISA. These experiments were repeated 3 times. Each error bar represents one standard deviation from the mean.
. Figure 11 . MTT Analysis of cytotoxicities of signaling pathway inhibitors (inhibitory rate curve). Cytotoxicities of signaling pathway inhibitors SB203580 (p38-MAPK inhibitor), U0126 (Erk1/2 inhibitor), SP600125 (JNK inhibitor), and PDTC (NF-κB inhibitor) were determined as an inhibition ratio, which is equal to (1 − (A − Ablank)/(Ac − Ablank)), in which A represents the A570nm of experimental groups (inhibitor agent-treated); Ablank represents background wavelength in blank wells (no cell and no agent); Ac represents A570nm in control groups, where cells were only treated with MTT agent, but not any inhibitor agent. These experiments were repeated 3 times. Each error bar represents one standard deviation from the mean. Figure 11 . MTT Analysis of cytotoxicities of signaling pathway inhibitors (inhibitory rate curve). Cytotoxicities of signaling pathway inhibitors SB203580 (p38-MAPK inhibitor), U0126 (Erk1/2 inhibitor), SP600125 (JNK inhibitor), and PDTC (NF-κB inhibitor) were determined as an inhibition ratio, which is equal to (1 − (A − A blank )/(A c − A blank )), in which A represents the A 570nm of experimental groups (inhibitor agent-treated); A blank represents background wavelength in blank wells (no cell and no agent); A c represents A 570nm in control groups, where cells were only treated with MTT agent, but not any inhibitor agent. These experiments were repeated 3 times. Each error bar represents one standard deviation from the mean. 
For further investigation of the signal pathways for PotD engaged in boosting pro-inflammatory cytokines, Western blotting was carried out to determine three MAPK pathways, including p38, ERK, JNK signal molecules, and another RelA(p65) signal molecule belonging to the NF-κB pathway. As outlined in Figure 12 , only the phosphorylation of JNK-MAPK in Raw 264.7 cells induced by PotD stimulation was augmented significantly, while the expression levels of the other signal molecules fluctuated within a statistically insignificant range (p > 0.05). The raw data of western blotting used in this study in Supplementary Materials, Figure S4 .
Expression of TLR2 and TLR4 in macrophages was further assayed in this test ( Figure 12 ). After treatment with PotD, TLR4 was significantly upregulated in Raw 264.7 compared with the negative control, while the expression of TLR2 was relatively constant. The WB results for TLR2 and 4 were similar to those in the TLR-blocked experiments as above, which confirmed the observation that TLR4, rather than TLR2, participates in regulatory role on expression of pro-inflammatory cytokines in Raw 264.7 macrophages.
(A) In a follow-up study, we aimed to characterize the details of the stimulation of signal pathway stimulation by rPotD, inhibitors SB203580 (p38-MAPK inhibitor), U0126 (Erk1/2-MAPK inhibitor), SP600125 (JNK-MAPK inhibitor), and PDTC (NF-κB inhibitor) were applied to block their corresponding signal pathway in Raw 264.7, with their supernatants being collected for detection of cytokines IL-1β, IL-6, and TNF-α via ELISA. Figure 13 plots the secretion levels of these three cytokines under different treatments, wherein a DMSO group was set as a control in parallel. Results showed that all these cytokines were downregulated significantly when the JNK-MAPK signal pathway was blocked, which coincided with our finding in the WB assay. However unexpected and noticeable, in ELISA, these cytokines were also downregulated when p65 (NF-κB) was blocked, Expression of TLR2 and TLR4 in macrophages was further assayed in this test (Figure 12 ). After treatment with PotD, TLR4 was significantly upregulated in Raw 264.7 compared with the negative control, while the expression of TLR2 was relatively constant. The WB results for TLR2 and 4 were similar to those in the TLR-blocked experiments as above, which confirmed the observation that TLR4, rather than TLR2, participates in regulatory role on expression of pro-inflammatory cytokines in Raw 264.7 macrophages.
In a follow-up study, we aimed to characterize the details of the stimulation of signal pathway stimulation by rPotD, inhibitors SB203580 (p38-MAPK inhibitor), U0126 (Erk1/2-MAPK inhibitor), SP600125 (JNK-MAPK inhibitor), and PDTC (NF-κB inhibitor) were applied to block their corresponding signal pathway in Raw 264.7, with their supernatants being collected for detection of cytokines IL-1β, IL-6, and TNF-α via ELISA. Figure 13 plots the secretion levels of these three cytokines under different treatments, wherein a DMSO group was set as a control in parallel. Results showed that all these cytokines were downregulated significantly when the JNK-MAPK signal pathway was blocked, which coincided with our finding in the WB assay. However unexpected and noticeable, in ELISA, these cytokines were also downregulated when p65 (NF-κB) was blocked, especially the secretion levels of IL-1 and -6. We postulated that ELISA is used to detect the functional output of the signal pathways and WB is used to detect the protein expression level change. Thus, we concluded that the NF-κB inhibitor (PDTC) also induced a certain degree of reduction. These results suggest that the PotD-induced cytokine production likely primarily depends on the phosphorylation of JNK-MAPK signal molecule and, to some extent, harnesses the NF-κB signal pathway as an alternative two-tiered circuit. especially the secretion levels of IL-1 and -6. We postulated that ELISA is used to detect the functional output of the signal pathways and WB is used to detect the protein expression level change. Thus, we concluded that the NF-κB inhibitor (PDTC) also induced a certain degree of reduction. These results suggest that the PotD-induced cytokine production likely primarily depends on the phosphorylation of JNK-MAPK signal molecule and, to some extent, harnesses the NF-κB signal pathway as an alternative two-tiered circuit. 
Discussion
Haemophilus parasuis, or Glaesserella parasuis (G. parasuis) according to the new taxonomic reclassification, is normally a benign swine commensal in upper respiratory tract but may cause severe vascular lesions and multiorgan dysfunction, eliciting serious economic losses annually worldwide [46, 47] . Commercial bacterins are often used to vaccinate swine against H. parasuis, but the deficiency in crossreactivity makes sole-serotype inactivated vaccine an ineffective means of protection against this disease [48] .
Polyamines, such as putrescine, cadaverine, spermidine and spermine, constitute a group of small, ubiquitous aliphatic, polycationic molecules which are present in all cells [49] . They play a myriad of cellular physiological roles in both eucaryotes, such as in mung bean sprouts and cancer cells, and in prokaryotes, such as Ebola virus and E. coli [50] [51] [52] [53] . In numerous landmark studies, the most important biological functions of polyamines have been well elucidated. However, only a small proportion of them have focused on the exact role of polyamines in microorganisms. A lipoprotein signal peptide was detected in the HpPotD with a cleavage site between position A22 and N23, and TMHMM2.0 server demonstrated that HpPotD has no typical transmembrane helix, suggesting that the protein is transported as a precursor protein through the cell membrane, lipid modified and retained at the inner membrane. This implied that this protein was more likely to be hydrophilic, which is consistent with the GRAVY value (−0.331) of HpPotD calculated by ExPASy ProtParam tool. Further studies concerning polyamine uptake and physiological functions in H. parasuis are needed.
Previous research findings confirmed the effectiveness of PotD protein in generating both vigorous and highly specific mucosal and systemic immune responses, and in reducing nasopharyngeal carriage and invasive disease caused by multiple pneumococcal serotypes [28] . Another recent study confirmed that chimeric proteins based on surface antigens PspA in fusion with 
Previous research findings confirmed the effectiveness of PotD protein in generating both vigorous and highly specific mucosal and systemic immune responses, and in reducing nasopharyngeal carriage and invasive disease caused by multiple pneumococcal serotypes [28] . Another recent study confirmed that chimeric proteins based on surface antigens PspA in fusion with PotD (rPspA-PotD fusion) were able to elicit strong immune responses and to protect against invasive pneumococcal infection, thus could reduce nasopharyngeal colonization in mice [54] . In our recent study, we found PotD can actively mediate both the humoral immune response and cellular immune response. Prior to determining whether SC1401 PotD can protect mouse from infection of the highly virulent H. parasuis strain SH0165 (serotype 5), we evaluated several immune indices. Through IF and FCM analysis, we found PotD could stimulate the expression levels of CD3 + , CD4 + and elevate CD4 + /CD8 + in mice when compared with mock groups. Lymphocyte proliferation results visually showed that mice can positively respond to PotD-stimulation. ELISA screens demonstrated that cytokines IL-1 and IFN-γ were boosted significantly after the primary spleen cells were exposed to PotD. However, the Th2-type immune response representative IL-4 was not affected. The observation of the effectively immunoprotective effect of PotD on the mouse model prompted us to further investigate the specific mechanisms of induction of immunity. Prior studies have noted the importance of TLRs in microbial identification and intrusion. Bacterial surface molecules are core factors in the microorganism-host crosstalk, a well-studied pattern by which TLRs recognize and bind with PAMPs/MAMPs [55] . Bacteria, viruses, fungi, and parasites can be recognized by TLR2. TLR4, with an adaptor molecule MyD88, is essential in the recognition of and response to antigenic components of multiple Gram-negative bacteria [56] . At present, in pro-inflammatory cytokines analysis and signal pathway investigation, we found TLR4 and not TLR2, was involved in positive control of cytokine production by PotD in H. parasuis, which was different from a previous finding for GALT in A. pleuropneumoniae, in which TLR2 played a contrary role against TLR4. The blocking of TLR2 significantly augmented expression levels of relative downstream pro-inflammatory cytokines induced by GALT in A. pleuropneumoniae [43] . However, the secretion levels of cytokines were still much higher than control through blocking TLR-4. We speculate that TLRs, especially TLR4 in this case, are not the only PRRs in the process of antigen recognition. More effort is needed to elaborate such a phenomenon. Further investigation in signal pathways confirmed that both JNK-MAPK and NF-κB play primary roles in the pro-inflammatory response induced by PotD stimulation in macrophages. Trigging expression of pro-inflammatory cytokines is a central phenomenon in mediating a variety of immune responses. Our research sheds light on the positive effect of PotD in aggravating inflammatory responses of macrophages in mice.
Conclusions
Taken together, one of the primary findings to emerge from this study is that the antibodies to the conserved polyamine transporter PotD confer effective protection against invasive GD within murine models, which hopefully lays a reasonable foundation for further verification of its immunoprotection in piglets. We also conclude that Hp-rPotD can actively elevate the secretion of pro-inflammatory cytokines IL-1, IL-6, and TNF-α of macrophages via JNK-MAPK and NF-κB signal pathways through TLR4, rather than TLR2. Our findings are hopefully expected to enrich the knowledge of developing improved strategies for the control of H. parasuis infection in the future.
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